Song Li, associate professor of pharmaceutical sciences, received $113,625 from the Department of Defense for “Targeted Co-Delivery of Synthetic microRNA and microRNA Expression Vector for Rapid and Sustained Inhibition of Breast Cancer.” The purpose of this study is to develop a novel nanotechnology for co-delivery of synthetic microRNA and microRNA expression plasmid. Successful completion of this study may lead to the development of an improved targeted therapy for the treatment of breast cancer.
